Vet Med - Czech, 2008, 53(4):214-220 | DOI: 10.17221/1921-VETMED

Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor metalloproteinase-2 in early stages of canine osteoarthritis

H.B. Lee1, M.R. Alam2, J.W. Seol1, N.S. Kim1
1 College of Veterinary Medicine, Chonbuk National University, Jeonju, Republic of Korea
2 Faculty of Veterinary Science, Bangladesh Agricultural University, Mymensingh, Bangladesh

The aim of this study was to determine if the activity of tartrate-resistant acid phosphatase (TRAP) in the synovial fluid (SF) and serum can be used as a marker for diagnosing the early stages of osteoarthritis (OA). We also wished to determine if identifiable differences in the concentrations of matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) could be detected in SF between normal joints and OA joints for the diagnosis of early OA. Ten skeletally mature beagle dogs underwent a unilateral surgical transection of the cranial cruciate ligament and medial meniscectomy. Five sham-operated beagle dogs were used as controls. The synovial fluid was collected in 1, 2 and 3 months and examined by western blotting for MMP-2 and ELISA for TIMP-2. The activity of TRAP in the SF and serum was measured using a spectrophotometer. In addition, the presence of TRAP positive cells in the synovium was identified by enzyme histochemistry. The level of the activity of TRAP and MMP-2 in the SF from the induced OA dogs was significantly higher than that of the control over a three-month period (P < 0.05). The TIMP-2 level in the SF was significantly lower in the induced OA dogs than in the control. However, there was no difference in TRAP activity in the serum. Histochemistry revealed a higher number of TRAP positive cells in the synovium from the induced OA dogs. Based on these data, we conclude that the activity of TRAP, MMP-2 and TIMP-2 in SF can be used as a biomarker to diagnose and monitor the early stages of OA.

Keywords: tartrate-resistant acid phosphatase; matrix metalloproteinase-2; tissue inhibitor of matrix metalloproteinase-2; osteoarthritis; synovial fluid

Published: April 30, 2008  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Lee HB, Alam MR, Seol JW, Kim NS. Tartrate-resistant acid phosphatase, matrix metalloproteinase-2 and tissue inhibitor metalloproteinase-2 in early stages of canine osteoarthritis. Vet Med-Czech. 2008;53(4):214-220. doi: 10.17221/1921-VETMED.
Download citation

References

  1. Adamopoulos I.E., Danks L., Itonaga I., Locklin R.M., Sabokbar A., Ferguson D.J., Athanasou N.A. (2006): Stimulation of osteoclast formation by inflammatory synovial fluid. Virchows Archiv, 449, 69-77. Go to original source... Go to PubMed...
  2. Adamopoulos I.E., Sabokbar A., Wordsworth B.P., Carr A., Ferguson D.J., Athanasou N.A. (2006): Synovial fluid macrophages are capable of osteoclast formation and resorption. The Journal of Pathology 208, 35-43. Go to original source... Go to PubMed...
  3. Budsberg S.C., Lenz M.E., Thonar E.J. (2006): Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection. American Journal of Veterinary Research 67, 429-432. Go to original source... Go to PubMed...
  4. Burrage P.S., Mix K.S., Brinckerhoff C.E. (2006): Matrix metalloproteinases: role in arthritis. Frontiers in Bioscience, 11, 529-543. Go to original source... Go to PubMed...
  5. Fox D.B., Cook J.L. (2001): Synovial fluid markers of osteoarthritis in dogs. Journal of the American Veterinary Medical Association 219, 756-761. Go to original source... Go to PubMed...
  6. Halleen J.M., Tiitinen S.L., Ylipahkala H., Fagerlund K. M., Vaananen H.K. (2006): Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clinical Laboratory, 52, 499-509.
  7. Hegemann N., Kohn B., Brunnberg L., Schmidt M.F. (2002): Biomarkers of joint tissue metabolism in canine osteoarthritic and arthritic joint disorders. Osteoarthritis and artilage/OARS, Osteoarthritis Research Society, 10, 714-721. Go to original source... Go to PubMed...
  8. Hegemann N., Wondimu A., Ullrich K., Schmidt M.F. (2003): Synovial MMP-3 and TIMP-1 levels and their correlation with cytokine expression in canine rheumatoid arthritis. Veterinary Immunology and Immunopathology, 91, 199-204. Go to original source... Go to PubMed...
  9. Henrotin Y., Sanchez C., Balligand M. (2005): Pharmaceutical and nutraceutical management of canine osteoarthritis: present and future perspectives. Veterinary Journal, 170, 113-123. Go to original source... Go to PubMed...
  10. Janckila A.J., Neustadt D.H., Nakasato Y.R., Halleen J.M., Hentunen T., Yam L.T. (2002): Serum tartrate-resistant acid phosphatase isoforms in rheumatoid arthritis. Clinica Chimica Acta; International Journal of Clinical Chemistry, 320, 49-58. Go to original source... Go to PubMed...
  11. Johnston S.A. (1997): Osteoarthritis: Joint anatomy, physiology, and pathobiology. The Veterinary Clinics of North America, Small Animal Praktice, 27, 699-723. Go to original source... Go to PubMed...
  12. Konttinen Y.T., Takagi M., Mandelin J., Lassus J., Salo J., Ainola M., Li T.F., Virtanen I., Liljestrom M., Sakai H., Kobayashi Y., Sorsa T., Lappalainen R., Demulder A., Santavirta S. (2001): Acid attack and cathepsin K in bone resorption around total hip replacement prosthesis. Journal of Bone and Mineral Research, 16, 1780-1786. Go to original source... Go to PubMed...
  13. Lang P., Schultzber, M., Andersso, G. (2001): Expression and distribution of tartrate-resistant purple acid phosphatase in the rat nervous system. The Journal of Histochemistry and Cytochemistry, 49, 379-396. Go to original source... Go to PubMed...
  14. Malemud C.J., Goldberg V.M. (1999): Future directions for research and treatment of osteoarthritis. Frontiers in Bioscience, 4, D762-771. Go to original source... Go to PubMed...
  15. Malemud C.J., Islam N., Haqqi T.M. (2003): Pathophysiological mechanisms in osteoarthritis lead to novel therapeutic strategies. Cells, Tissues, Organs, 174, 34-48. Go to original source... Go to PubMed...
  16. Manicourt D.H., Fujimoto N., Obata K., Thonar E.J. (1994): Serum levels of collagenase, stromelysin-1, and TIMP-1. Age- and sex-related differences in normal subjects and relationship to the extent of joint involvement and serum levels of antigenic keratan sulfate in patients with osteoarthritis. Arthritis and Rheumatism, 37, 1774-1783. Go to original source... Go to PubMed...
  17. Muir P., Schamberger G.M., Manley P.A., Hao Z. (2005): Localization of cathepsin K and tartrate-resistant acid phosphatase in synovium and cranial cruciate ligament in dogs with cruciate disease. Veterinary Surgery, 34, 239-246. Go to original source... Go to PubMed...
  18. Pay S., Erdem H., Serdar M., Dinc A., Simsek I., Turan M. (2002): Comparison of synovial MMP-1 and TIMP-1 levels in patients with various inflammatory arthritides: is there any difference between rheumatoid arthritis, Behcet's disease and familial Mediterranean fever. Clinical Rheumatology, 21, 511-515. Go to original source... Go to PubMed...
  19. Rosemann T., Laux G., Szecsenyi J. (2007): Osteoarthritis: quality of life, comorbidities, medication and health service utilization assessed in a large sample of primary care patients. Journal of Orthopaedic Surgery, 2, 12. Go to original source... Go to PubMed...
  20. Salinardi B.J., Roush J.K., Schermerhorn T., Mitchell,K.E. (2006): Matrix metalloproteinase and tissue inhibitor of metalloproteinase in serum and synovial fluid of osteoarthritic dogs. Veterinary and Comparative Orthopaedics and Traumatology, 19, 49-55. Go to original source...
  21. Tsuboi H., Matsui Y., Hayashida K., Yamane S., MaedaTanimura M., Nampei A., Hashimoto J., Suzuki R., Yoshikawa H., Ochi T. (2003): Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Annals of the Rheumatic Diseases, 62, 196-203. Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International (CC BY NC 4.0), which permits non-comercial use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.